Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Other financing activities (2023 - 2024)

Historic Other financing activities for Monte Rosa Therapeutics (GLUE) over the last 2 years, with Q4 2024 value amounting to $229000.0.

  • Monte Rosa Therapeutics' Other financing activities fell 1672.73% to $229000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $504000.0, marking a year-over-year change of. This contributed to the annual value of $527000.0 for FY2024, which is 882.35% down from last year.
  • As of Q4 2024, Monte Rosa Therapeutics' Other financing activities stood at $229000.0, which was down 1672.73% from $275000.0 recorded in Q4 2023.
  • In the past 5 years, Monte Rosa Therapeutics' Other financing activities ranged from a high of $275000.0 in Q4 2023 and a low of $229000.0 during Q4 2024